New Monoclonal Antibodies Adding Power to CLL Treatment
The monoclonal antibody, Rituximab, has been a backbone of CLL treatment for several years. It targets a protein on the CLL cells. Now a more powerful antibody may be available soon and has shown prom...
Author: patientpower
Added: 09/17/2013
Source: Oncology Tube - Category: Cancer & Oncology Source Type: podcasts
More News: Cancer & Oncology | Rituxan